These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21263054

  • 1. Pharmacodynamics of razupenem (PZ601) studied in an in vitro pharmacokinetic model of infection.
    MacGowan AP, Noel A, Tomaselli S, Elliott H, Bowker K.
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1436-42. PubMed ID: 21263054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
    MacGowan AP, Bowker KE, Noel AR.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1401-6. PubMed ID: 18227179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection.
    Bowker KE, Noel AR, Tomaselli S, MacGowan AP.
    J Antimicrob Chemother; 2016 May; 71(5):1270-8. PubMed ID: 26846209
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more β-lactamases and methicillin-resistant Staphylococcus aureus carrying various staphylococcal cassette chromosome mec types.
    Castanheira M, Sader HS, Farrell DJ, Mendes RE, Jones RN.
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4779-85. PubMed ID: 22733066
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
    Clark C, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Appelbaum PC.
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3118-21. PubMed ID: 19433566
    [Abstract] [Full Text] [Related]

  • 17. Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms.
    Livermore DM, Mushtaq S, Warner M.
    J Antimicrob Chemother; 2009 Aug; 64(2):330-5. PubMed ID: 19497942
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of the antibacterial effect of and emergence of resistance to doripenem in Pseudomonas aeruginosa and Acinetobacter baumannii in an in vitro pharmacokinetic model.
    Bowker KE, Noel AR, Tomaselli SG, Elliott H, Macgowan AP.
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5009-15. PubMed ID: 22713338
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of human-simulated exposures of tomopenem (formerly CS-023) in a murine model of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus infection.
    Sugihara K, Tateda K, Yamamura N, Koga T, Sugihara C, Yamaguchi K.
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5004-9. PubMed ID: 21844314
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.